Straumann Holding AG (OTCMKTS:SAUHY) Given Consensus Recommendation of “Hold” by Analysts

Shares of Straumann Holding AG (OTCMKTS:SAUHY) have received an average recommendation of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company.

A number of analysts have commented on SAUHY shares. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a report on Monday, December 15th. UBS Group upgraded Straumann from a “sell” rating to a “neutral” rating in a report on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft upgraded shares of Straumann from a “hold” rating to a “buy” rating in a research note on Friday, October 31st. Citigroup reaffirmed a “sell” rating on shares of Straumann in a report on Wednesday, January 14th. Finally, The Goldman Sachs Group cut shares of Straumann from a “strong-buy” rating to a “neutral” rating in a report on Monday, October 13th.

Straumann Stock Performance

Shares of OTCMKTS SAUHY opened at $12.32 on Thursday. Straumann has a twelve month low of $10.30 and a twelve month high of $15.00. The company has a 50 day moving average of $11.92 and a 200 day moving average of $11.91.

About Straumann

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.